AZULFIDINE

This brand name is authorized in Germany, Japan, United States

Active ingredients

The drug AZULFIDINE contains one active pharmaceutical ingredient (API):

1 Sulfasalazine UNII 3XC8GUZ6CB - SULFASALAZINE

Therapeutic benefit of sulfasalazine appears to be due to a local action of the sulfasalazine and its split product 5-aminosalicylic acid on the mucous membrane and deeper colonic structures. Read about Sulfasalazine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
AZULFIDINE Tablet	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A07EC01	Sulfasalazine	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07E Intestinal antiinflammatory agents → A07EC Aminosalicylic acid and similar agents
Discover more medicines within A07EC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 01251483, 01923474, 04832252
Country: JP	医薬品医療機器総合機構	Identifier(s): 6219001H1056, 6219001H2036
Country: US	FDA, National Drug Code	Identifier(s): 0013-0101, 0013-0102